152 related articles for article (PubMed ID: 25328285)
1. Troglitazone and Δ2Troglitazone enhance adiponectin expression in monocytes/macrophages through the AMP-activated protein kinase pathway.
Tsai JS; Chuang LM; Chen CS; Liang CJ; Chen YL; Chen CY
Mediators Inflamm; 2014; 2014():726068. PubMed ID: 25328285
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone inhibits monocyte/macrophage adhesion through de novo adiponectin production in human monocytes.
Tsai JS; Chen CY; Chen YL; Chuang LM
J Cell Biochem; 2010 Aug; 110(6):1410-9. PubMed ID: 20506517
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
Tanaka T; Fukunaga Y; Itoh H; Doi K; Yamashita J; Chun TH; Inoue M; Masatsugu K; Saito T; Sawada N; Sakaguchi S; Arai H; Nakao K
Eur J Pharmacol; 2005 Jan; 508(1-3):255-65. PubMed ID: 15680279
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma-independent repression of prostate-specific antigen expression by thiazolidinediones in prostate cancer cells.
Yang CC; Ku CY; Wei S; Shiau CW; Chen CS; Pinzone JJ; Ringel MD; Chen CS
Mol Pharmacol; 2006 May; 69(5):1564-70. PubMed ID: 16452400
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells.
Huang JW; Shiau CW; Yang YT; Kulp SK; Chen KF; Brueggemeier RW; Shapiro CL; Chen CS
Mol Pharmacol; 2005 Apr; 67(4):1342-8. PubMed ID: 15653552
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages.
Lovren F; Pan Y; Quan A; Szmitko PE; Singh KK; Shukla PC; Gupta M; Chan L; Al-Omran M; Teoh H; Verma S
Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H656-63. PubMed ID: 20622108
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.
Collins AR; Meehan WP; Kintscher U; Jackson S; Wakino S; Noh G; Palinski W; Hsueh WA; Law RE
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):365-71. PubMed ID: 11231915
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone, a PPARgamma ligand, inhibits osteopontin gene expression in human monocytes/macrophage THP-1 cells.
Oyama Y; Kurabayashi M; Akuzawa N; Nagai R
J Atheroscler Thromb; 2000; 7(2):77-82. PubMed ID: 11426586
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin limits monocytic microparticle-induced endothelial activation by modulation of the AMPK, Akt and NFκB signaling pathways.
Ehsan M; Singh KK; Lovren F; Pan Y; Quan A; Mantella LE; Sandhu P; Teoh H; Al-Omran M; Verma S
Atherosclerosis; 2016 Feb; 245():1-11. PubMed ID: 26687997
[TBL] [Abstract][Full Text] [Related]
10. Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling.
Yan J; Yang H; Wang G; Sun L; Zhou Y; Guo Y; Xi Z; Jiang X
Autophagy; 2010 Jan; 6(1):67-73. PubMed ID: 19923924
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
Hamaguchi E; Takamura T; Shimizu A; Nagai Y
J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
[TBL] [Abstract][Full Text] [Related]
13. Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-Troglitazone-induced Apoptosis in Prostate Cancer Cells Involve AMP-activated Protein Kinase.
Santha S; Viswakarma N; Das S; Rana A; Rana B
J Biol Chem; 2015 Sep; 290(36):21865-75. PubMed ID: 26198640
[TBL] [Abstract][Full Text] [Related]
14. Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-gamma activations in endothelial cells.
Nizamutdinova IT; Kim YM; Kim HJ; Seo HG; Lee JH; Chang KC
Atherosclerosis; 2009 Dec; 207(2):405-11. PubMed ID: 19524923
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells.
Zhu M; Flynt L; Ghosh S; Mellema M; Banerjee A; Williams E; Panettieri RA; Shore SA
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):111-9. PubMed ID: 20870897
[TBL] [Abstract][Full Text] [Related]
16. AICAR inhibits PPARγ during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids.
Namgaladze D; Kemmerer M; von Knethen A; Brüne B
Cardiovasc Res; 2013 Jun; 98(3):479-87. PubMed ID: 23531513
[TBL] [Abstract][Full Text] [Related]
17. Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.
Huypens P; Quartier E; Pipeleers D; Van de Casteele M
Eur J Pharmacol; 2005 Aug; 518(2-3):90-5. PubMed ID: 16039647
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A/T-rich sequence in THP-1 cells.
Oyama Y; Akuzawa N; Nagai R; Kurabayashi M
Circ Res; 2002 Feb; 90(3):348-55. PubMed ID: 11861425
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin enhances intercellular adhesion molecule-1 expression and promotes monocyte adhesion in human synovial fibroblasts.
Chen HT; Tsou HK; Chen JC; Shih JM; Chen YJ; Tang CH
PLoS One; 2014; 9(3):e92741. PubMed ID: 24667577
[TBL] [Abstract][Full Text] [Related]
20. Globular adiponectin inhibits ethanol-induced reactive oxygen species production through modulation of NADPH oxidase in macrophages: involvement of liver kinase B1/AMP-activated protein kinase pathway.
Kim MJ; Nagy LE; Park PH
Mol Pharmacol; 2014 Sep; 86(3):284-96. PubMed ID: 24850909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
